Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Iatreia
Print version ISSN 0121-0793
Abstract
FLOREZ-MORALES, Isabel; BERTEL-RODRIGUEZ, Daniela; CORREA-LONDONO, Luis Alfonso and VELASQUEZ-LOPERA, Margarita María. Report of the experience of the Section of Dermatology of the University of Antioquia, Medellin, in the fifth working day of detection of skin cancer, Asocolderma 2016. Iatreia [online]. 2018, vol.31, n.4, pp.362-370. ISSN 0121-0793. https://doi.org/10.17533/udea.iatreia.v31n4a03.
Introduction:
Skin cancer screening days are a tool for the early identification and education of affected individuals. We present the results of the participation of the Dermatology Service of the University of Antioquia on the fifth campaign of the Colombian Association of Dermatology and Dermatologic Surgery, held on August 25 and 26, 2016.
Methods:
Patients Older than 18 years and minors with parental consent. We performed clinical evaluation of total body skin and histopathological analysis of suspected skin cancer lesions, with prior written informed consent.
Results:
A total of 132 patients were attended, 33 were suspected lesions, 22 were biopsied, 9 underwent clinical diagnosis of actinic keratoses, 1 atypical nevus and 1 both diagnosis. In 11 patients skin cancer was diagnosed, one with two malignant melanomas, one with squamous cell carcinoma and nine with basal cell carcinoma.
Discussion:
25 % of the attendees presented suspicious injuries. Basal cell carcinoma was the most common type of cancer, 6.06 %, followed by squamous cell carcinoma 0.75 % and malignant melanoma 0.75 %. Concern about risk behavior of sun exposure; of patients with premalignant or malignant lesions, 40.6 % reported sunburn before age 18 and 48.5% practiced activities in the sun. Phototypes II and III predominate in 83.4 %, which increases the risk of skin cáncer
Keywords : Basal Cell Carcinoma; Mass Screening; Melanoma; Skin Cancer; Squamous Cell Carcinoma.